Viatris has signed definitive agreements for the sale of its equity stake in Biocon Biologics to Biocon for $815m.

Agilent Technologies has expanded its collaboration with Monash University Malaysia (MUM) for the establishment of a ...

Opinions amongst the CDC's ACIP were divided on the continued use of the hepatitis B vaccine in a paediatric population.

By analyzing real-world data, digital health organizations can gain insights into actual costs, measure outcomes, and build ...

The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...

Denali has entered a $275m royalty funding agreement with Royalty Pharma based on future net sales of tividenofusp alfa therapy.

Takeda and Innovent have closed their global partnership for next-generation IO and ADC therapies after fulfilment of ...

The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...

The commissioners’ concerns are in response to sweeping vaccine regulation changes earmarked by CBER head Vinay Prasad.

Høeg’s appointment to director of the FDA's CDER follows a turbulent period for the department, which has seen five leaders ...

Formosa Pharmaceuticals and Rxilient Medical have agreed on the commercialisation of APP13007 in ASEAN markets.

If Richard Padzur retires, he would become one of several high-ranking FDA officials who left the agency in 2025.